Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03153007 · ClinicalTrials.gov registry record
Study of Subjects With Diabetic Foot Ulcer (DFU)
A clinical trial of Diabetic Foot, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- 1
- Enrollment target
- 1
- Study location
NCT03153007 is a study of Diabetic Foot that has completed, run by GlaxoSmithKline. The registered enrollment target is 1 participants, below the 10,341-participant average among 30 other Diabetic Foot trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03153007, a study of Diabetic Foot, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- 1 participants
- Enrollment target
- 1
- Study location
Study Summary
Foot ulceration is a common and costly complication of diabetes. GSK1278863 is a topical drug, which is being developed to treat wounds associated with DFU. The aim of this study is to explore the symptoms and impacts of DFU from the subject perspective and to elicit in-depth information about DFU signs and symptoms, impacts on functioning and health-related quality of life (HRQoL). Adult DFU subjects with current or recent (within last six months) neuropathic foot ulcers will be eligible to participate in this prospective, cross-sectional interview study. Approximately 20 DFU subjects will be recruited from up to three clinical sites. Potential subjects will be pre-screened and then contacted to gauge interest in the study. Interested subjects will be screened and eligible subjects will consent to release contact information to research staff. Research staff will contact the subject to schedule interviews. This study will include concept elicitation interviews over the telephone or in-person by trained and experienced interviewers. In-person interviews will be conducted in a private room at the clinical site. All interviews will be conducted in English and will be guided by semi-structured interview guides. All subjects will provide written consent prior to the start of the interview.
Conditions Studied
Study Locations (1)
Maryland
- GSK Investigational Site - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2017-08-11 |
| Est. Completion | 2017-12-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03153007
The ClinicalTrials.gov registry entry for NCT03153007 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 10,341-participant average among 30 other Diabetic Foot trials with a reported enrollment target (100% lower). The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetic Foot appearing as the primary indexed condition, and to 0 interventions.
NCT03153007 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT03153007 about?
NCT03153007 is a clinical study titled "Study of Subjects With Diabetic Foot Ulcer (DFU)". Foot ulceration is a common and costly complication of diabetes. GSK1278863 is a topical drug, which is being developed to treat wounds associated with DFU. The aim of this study is to explore the symptoms and impacts of DFU from the subject perspective and to elicit in-depth information about DFU s...
What is the current status of trial NCT03153007?
This trial is currently completed. The enrollment target is 1 participants. The study started on 2017-08-11. Estimated completion is 2017-12-06.
What conditions does trial NCT03153007 study?
This clinical trial studies the following conditions: Diabetic Foot.
Who is sponsoring clinical trial NCT03153007?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03153007 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
RECRUITING
-
Effectiveness of Remote Foot Temperature Monitoring
RECRUITING · NA
-
A Real-World Registry of Chronic Wounds and Ulcers
RECRUITING
-
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
RECRUITING · NA
-
A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.